Prasannabiomolecules Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-06-2024
- Paid Up Capital ₹ 0.10 M
as on 29-06-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.83 Cr
as on 29-06-2024
- Revenue 45.35%
(FY 2023)
- Profit 83.62%
(FY 2023)
- Ebitda 72.90%
(FY 2023)
- Net Worth 97.08%
(FY 2023)
- Total Assets 46.33%
(FY 2023)
About Prasannabiomolecules
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹12.83 Cr.
Kavuri Rao and Kavuri Anusha serve as directors at the Company.
- CIN/LLPIN
U24304TG2017PTC119638
- Company No.
119638
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Prasannabiomolecules Private Limited offer?
Prasannabiomolecules Private Limited offers a wide range of products and services, including Organic and Inorganic Solvents, Carboxylate Esters, Medical Laboratory Instruments, VTM Kit Raw Materials, Aromatic Hydrocarbon Solvent, Inorganic Chemicals, Chemical Reagents & Catalysts, Inorganic Salts, Pharma Ingredients & Raw Materials, Pyridine Derivatives.
Who are the key members and board of directors at Prasannabiomolecules?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kavuri Rao  | Managing Director | 19-Sep-2017 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kavuri Anusha | Director | 22-Aug-2018 | Current |
Financial Performance of Prasannabiomolecules.
Prasannabiomolecules Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 45.35% increase. The company also saw a substantial improvement in profitability, with a 83.62% increase in profit. The company's net worth Soared by an impressive increase of 97.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prasannabiomolecules?
In 2022, Prasannabiomolecules had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prasanna Lifesciences Private LimitedActive 6 years 8 monthsKavuri Rao and Kavuri Anusha are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 05 Sep 2023 | ₹2.11 M | Open |
Hdfc Bank Limited Creation Date: 28 Mar 2023 | ₹12.62 Cr | Open |
How Many Employees Work at Prasannabiomolecules?
Unlock and access historical data on people associated with Prasannabiomolecules, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prasannabiomolecules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prasannabiomolecules's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
